Issue #1 · April 13, 2026 · Prepared by Prof. Jim Liew + the AI Swarm
Tracked idea: LONG ZION (Zions Bancorporation) into Q1 2026 earnings
Red-Team confidence: 70 / 100 (below our 75 publishing gate — see Section 0)
Time horizon: 7 days (Q1 2026 earnings, April 20 after close)
Reference price at publication: $61.53 (ZION close, April 13, 2026)
Implied options move (est.): ~±5% (typical regional-bank earnings vol)
Forward P/E: 9.94x vs. regional-bank median ~10.3x (≈3.5% discount)
Public scorecard: live performance tracker View the scorecard
0. Editorial Disclosure — why this issue ships below our gate
Our editorial policy sets a 75/100 Red-Team gate for paid-tier ideas. This issue lands at 70. We are publishing Issue #1 anyway, for three reasons:
Transparency is the product. If we bury thesis drift, we are no better than the free stock-pickers on Twitter.
The process works. The swarm flagged the shrinking valuation gap overnight. The confidence score responded the way it is designed to.
Pedagogical value for subscribers. How the Red-Team agent downgraded confidence as the peer spread compressed is exactly what you are paying us to see.
Sizing guidance: treat this as a half-sized tactical position, not a core holding. Future issues below 75 will be held back.
1. The Setup — what we still see
Three things the market has not yet fully priced into ZION at 9.94x forward:
1. The consolidation wave just beheaded ZION's peer group. Fifth Third closed its $12.3B acquisition of Comerica on Feb 16, 2026. ZION — ~$90B in assets, dominant deposit franchise across Utah, Nevada, Arizona, and Idaho — is now one of the last independent premium Mountain West banks. Scarcity value is modest but real; historical regional-bank takeout premiums of 1.3–1.6× tangible book translate to roughly $58–$69 for ZION. Today's $61.53 sits inside that band — not at the floor. This is no longer a takeout-discount story; it is a takeout-optionality story.
2. Credit quality is improving, not deteriorating. Q4 2025 classified CRE balances declined $35M sequentially. The office book is $1.8B (just 3% of total loans) with a 3.3% allowance for credit losses.
3. NIM is on an 8-consecutive-quarter expansion streak. Q4 2025 NIM hit 3.31% (+26 bp YoY). February commentary from management pointed to +10–11% annualized loan growth with C&I up 22%.
What changed vs our draft: ZION re-rated through most of the discount between our drafting date and publication. The peer-median-rerate payoff shrank from roughly +14% to roughly +3.5%. The catalyst path (next section) is now doing most of the work, not the valuation gap.
2. The Swarm's Thesis — tightened
Three scenarios, probability-weighted at $61.53 entry:
Scenario | Probability | Drivers | Implied 1-week reaction | Price target |
|---|---|---|---|---|
Bull | 25% | NIM beat + constructive CRE tone + guide raise + takeout chatter | +6 to +9% | $65–$67 |
Base | 50% | In-line EPS, NIM in line, cautious-but-not-bearish CRE commentary | −1 to +3% | $61–$63 |
Bear | 25% | Missed EPS, NIM peaks, fresh CRE loss disclosed | −7 to −10% | $55–$57 |
Probability-weighted expected return: ~+0.6% over 7 days. Asymmetry (bull +7.5% vs bear −8.5%) is close to symmetric. The trade is about event exposure with defined kill lines on a franchise we believe is structurally mispriced on optionality, not multiple.
3. The Data
ZION Q4 2025 snapshot (source: Q4 earnings release):
Net income: $262M (+19% QoQ, +31% YoY)
NIM: 3.31% (+3 bp QoQ, +26 bp YoY, 8 consecutive quarters of expansion)
Total loans: ~$61B
CRE book: $13.4B (22% of loans), classified balances declining
Office portfolio: $1.8B (3% of loans), 3.3% ACL, 28% near-term maturity
CET1 ratio: 11.5%
Total assets: ~$90B
Q1 2026 consensus (source: sell-side):
EPS: $1.20 (+16.5% YoY)
Revenue: $808.3M (+7.5% YoY)
30-day EPS estimate revision: −0.8% (sell-side trimmed — a lower bar to clear)
Peer-group forward P/E snapshot (close, April 13, 2026):
Bank | Fwd P/E | NIM Q4 2025 | CRE % of Loans |
|---|---|---|---|
ZION | 9.94x | 3.31% | 22% |
RF | ~10.1x | ~3.5% | ~13% |
MTB | ~10.2x | ~3.6% | ~25% |
KEY | ~10.5x | ~2.6% | ~10% |
FITB (post-CMA) | ~10.8x | ~3.1% | ~18% |
HBAN | ~11.0x | ~3.1% | ~15% |
Regional median | ~10.3x | ~3.1% | ~15% |
The gap: ZION trades at roughly a 3.5% forward-P/E discount to the regional-bank median. A simple re-rate to median implies $63.75 (+3.6%). That is the base case — nothing heroic.
4. The Catalyst Path
April 15 — M&T Bank (MTB) reports. Peer read on Mid-Atlantic CRE conditions.
April 17 — KEY, HBAN, FITB (first post-CMA print) likely report. Watch FITB commentary on regional-consolidation economics. Takeout-premium chatter could roll into ZION.
April 20 (after close) — ZION Q1 2026 earnings. The event.
April 28–29 — FOMC meeting. Consensus: no move, hold at 3.50–3.75%. ZION's 2026 NII guide assumes two 25bp cuts later in the year — Fed-signal delay = guide-risk asymmetry.
5. The Red-Team Critique (why we are at 70, not 78)
Five reasons we could be wrong (verbatim from the swarm's adversarial agent):
The discount has mostly closed. At 9.94x vs peer median 10.3x, the re-rate payoff is roughly +3.6% — easily wiped out by any earnings wobble. This is the single biggest reason confidence dropped.
Takeout-premium math is thin here. 1.3–1.6× tangible book = $58–$69 envelope. Today's $61.53 is already mid-envelope. Optionality, not cushion.
The rate-cut-dependent guide is fragile. Management's 2026 NII outlook assumes 2× 25bp cuts. A hawkish April FOMC surprise hurts the NIM tailwind into H2.
Office at 28% near-term maturity is a latent problem. If Western office values take another leg down (~10–15%), the 3.3% ACL underreserves by 50–100 bps.
Consensus already embeds +16.5% YoY EPS growth. An in-line base-case print may disappoint holders who bought the beat.
6. What Would Change Our Mind (kill criteria)
Any of these land → exit:
Any pre-announcement from ZION or a Western-US regional flagging CRE or fraud-related charge-offs before April 20
MTB or KEY Q1 prints materially missing on NIM or credit metrics (peer contagion)
A pre-April-20 move above $67 that eats the bull-case asymmetry before the event
FOMC language shift from April-28 Powell signaling no cuts in 2026 (kills the NIM tailwind in the guide)
7. Scorecard Entry
Field | Value |
|---|---|
Idea # | 001 |
Ticker | ZION |
Direction | LONG |
Reference close date | 2026-04-13 |
Entry reference price | $61.53 |
Confidence | 70/100 (below 75 gate — see Section 0) |
Horizon | 7 days (through 2026-04-20 earnings) |
Target band | $63–$67 (base–bull) |
Kill line | $57.00 (−7.4%) intraday, or pre-announcement risk-off |
Live public scorecard: View the scorecard
Sources
Zions Q4 2025 earnings release — prnewswire.com
Zions Q4 2025 earnings call transcript — fool.com
Zions FY2024 10-K
Fifth Third completes Comerica acquisition — FinancialContent
California landlord fraud fuels regional-bank losses — CRE Daily
Zions Q1 2026 earnings preview — Nasdaq
FOMC April 2026 meeting calendar — federalreserve.gov
American Banker — Zions confident in credit despite CRE risk
Positions
Prof. Jim Liew does not currently hold a position in ZION. Neither does SoKat LLC. The AI swarm agents do not hold positions.
Disclaimer
The Liew Letter is published by SoKat LLC for informational and educational purposes only. Content represents the opinions of the author based on publicly available information at time of publication. Nothing here is investment, legal, or tax advice, nor a solicitation to buy or sell any security. No personalized recommendations are made. Past performance and backtested results are not indicative of future returns. Readers should conduct their own research and consult a licensed advisor before making investment decisions. © 2026 SoKat LLC. All rights reserved.